Table 4.
Cancer incidence by country among 148 666 male Nordic seafarers and fishermen; 1961–2005. Statistically significant results marked in bold. [Obs=observed; SIR=standardized incidence ratio; CI=confidence interval]. Outcomes of a priori interest or with more than 1000 observed cases shown. When the observed number of cases is zero, the expected number is presented in parentheses.
| Cancer site | Seafarers | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Denmark (N=8936) | Finland (N=10 230) | Iceland (N=1001) | Norway (N=42 936) | Sweden (N=18 637) | ||||||
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | |
| All cancers a | 2243 | 1.27 (1.21–1.32) | 1748 | 1.20 (1.14–1.25) | 141 | 1.26 (1.06–1.48) | 10 231 | 1.20 (1.17–1.22) | 4161 | 1.24 (1.20–1.27) |
| Lip | 28 | 1.44 (0.96–2.09) | 23 | 1.25 (0.79–1.87) | 0.62 | 0 | 92 | 1.06 (0.85–1.30) | 42 | 1.42 (1.03–1.92) |
| Stomach | 88 | 1.32 (1.06–1.63) | 90 | 1.08 (0.86–1.32) | 7 | 1.16 (0.47–2.39) | 678 | 1.27 (1.17–1.36) | 212 | 1.15 (1.01–1.32) |
| Colon | 195 | 1.26 (1.09–1.46) | 91 | 1.24 (1.00–1.52) | 13 | 1.50 (0.80–2.56) | 813 | 1.05 (0.98–1.12) | 285 | 1.12 (1.00–1.26) |
| Lung | 546 | 1.42 (1.30–1.54) | 353 | 1.19 (1.07–1.32) | 23 | 1.57 (0.99–2.35) | 2036 | 1.74 (1.67–1.82) | 624 | 1.82 (1.68–1.97) |
| Mesothelioma | 26 | 2.51 (1.64–3.68) | 18 | 2.68 (1.59–4.23) | 1 | 2.48 (0.07–15.80) | 61 | 1.74 (1.33–2.24) | 37 | 2.77 (1.95–3.81) |
| Prostate | 263 | 1.13 (0.99–1.27) | 418 | 1.19 (1.09–1.32) | 25 | 0.84 (0.55–1.25) | 1860 | 0.99 (0.94–1.03) | 1047 | 1.12 (1.05–1.18) |
| Urinary bladder | 231 | 1.19 (1.04–1.35) | 108 | 1.34 (1.11–1.61) | 12 | 1.42 (0.74–2.48) | 813 | 1.21 (1.13–1.29) | 314 | 1.24 (1.11–1.38) |
| Fishermen | ||||||||||
| Denmark (N=7053) | Finland (N=2970) | Iceland (N=4907) | Norway (N=42 711) | Sweden (N=9285) | ||||||
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | |
| All cancers a | 1821 | 1.12 (1.07–1.17) | 522 | 0.94 (0.86–1.03) | 429 | 1.07 (0.97–1.18) | 10 870 | 1.02 (1.00–1.04) | 2214 | 0.97 (0.92–1.01) |
| Lip | 57 | 3.19 (2.42–4.14) | 14 | 1.79 (0.98–3.00) | 1 | 0.51 (0.01–2.84) | 232 | 1.92 (1.69–2.19) | 80 | 3.65 (2.90–4.55) |
| Stomach | 80 | 1.26 (1.00–1.57) | 35 | 0.99 (0.69–1.37) | 25 | 1.21 (0.78–1.79) | 1113 | 1.41 (1.33–1.50) | 175 | 1.23 (1.06–1.43) |
| Colon | 154 | 1.07 (0.91–1.25) | 22 | 0.80 (0.50–1.22) | 32 | 1.06 (0.72–1.49) | 892 | 0.91 (0.85–0.97) | 171 | 0.95 (0.82–1.11) |
| Lung | 460 | 1.28 (1.17–1.41) | 127 | 1.02 (0.86–1.22) | 78 | 1.52 (1.20–1.89) | 1654 | 1.17 (1.11–1.22) | 227 | 0.96 (0.84–1.09) |
| Mesothelioma | 4 | 0.43 (0.12–1.10) | 1 | 0.49 (0.01–2.71) | 1 | 0.74 (0.02–4.13) | 16 | 0.43 (0.24–0.69) | 4 | 0.49 (0.13–1.25) |
| Prostate | 203 | 0.89 (0.77–1.03) | 127 | 0.97 (0.81–1.15) | 95 | 0.98 (0.80–1.20) | 2219 | 0.88 (0.84–0.92) | 585 | 0.89 (0.82–0.97) |
| Urinary bladder | 205 | 1.13 (0.98–1.30) | 23 | 0.71 (0.45–1.07) | 34 | 1.15 (0.80–1.61) | 1005 | 1.17 (1.10–1.24) | 183 | 1.05 (0.91–1.22) |
a
All cancers minus non-melanoma skin cancer.